
Delilah Alvarado
Staff ReporterDelilah is a staff reporter for BioPharma Dive. Before Industry Dive she covered business tech and startup news and has reported on social issues, politics and culture. She has a B.S. from Texas State University and is obsessed with dogs and horror films.
216 articles by Delilah Alvarado
-
Novo to expand French plant in GLP-1 production push
Nov. 27, 2023 -
Merck to buy private biotech Caraway in neuroscience deal
Nov. 21, 2023 -
Homology enters reverse merger with Q32 Bio
Nov. 16, 2023 -
Alkermes separates cancer drug business as new company Mural
Nov. 15, 2023 -
Forbion-backed biotech raises $138M to develop ALS drug
Nov. 14, 2023 -
Valneva’s chikungunya vaccine approved by FDA
Nov. 10, 2023 -
Takeda secures FDA approval for colon cancer drug
Nov. 9, 2023 -
Flagship expands into Asia-Pacific with new Singapore hub
Nov. 7, 2023 -
Ventyx revises TYK2 drug plans after lackluster study data
Nov. 7, 2023 -
Moderna adjusts to changing outlook for COVID vaccine demand
Nov. 3, 2023 -
Sangamo to cut jobs again with planned business overhaul
Nov. 2, 2023 -
Pfizer RSV vaccine gets off to fast start on market
Oct. 31, 2023 -
Sanofi invests in MeiraGTx and its gene-regulating technology
Oct. 30, 2023 -
Lessons from a biotech downturn: Funding challenges, an IPO dry spell and what to expect in 2024
Oct. 26, 2023 -
Supply shortage hits infant RSV antibody Beyfortus
Oct. 25, 2023 -
OrbiMed raises $4.3B in new funds for startup investing
Oct. 24, 2023 -
Pfizer wins FDA approval of new meningococcal vaccine
Oct. 23, 2023 -
Concentra makes bid for struggling biotech Rain
Oct. 16, 2023 -
‘Project NextGen’ picks new mRNA, intranasal COVID vaccines for funding
Oct. 13, 2023 -
Research group says FDA found no misconduct in Pfizer Lyme vaccine trial it helped run
Oct. 12, 2023 -
Bayer opens California plant to make cell therapies
Oct. 10, 2023 -
GSK partners with Chinese pharma to expand Shingrix sales
Oct. 9, 2023 -
Moderna claims positive results in early study for combo COVID, flu shot
Oct. 4, 2023 -
Lilly eczema drug turned back by FDA over manufacturing
Oct. 2, 2023 -
PTC to lay off more staff following drug setback in Europe
Sept. 29, 2023